Drug combinations can improve drug resistance by targeting multiple pathways or mechanisms simultaneously, making it more difficult for the cancer cells to develop resistance.

Liposomal drug delivery systems are unique formulations that have gained significant attention in recent years due to their ability to enhance the pharmacokinetics and targeting of certain medications.

Developing effective gene delivery systems for gene therapy is a significant challenge due to several factors.

Federal regulations require that applicable clinical trials and NIH-funded clinical trials be registered no later than 21 days after enrollment of the first participant.

When placing physical distances in the workplace in the event of an infectious disease, it is important to consider several factors.

Mucoadhesive drug delivery systems (MDDS) are designed to enhance the residence time of a drug at a specific site in the body, primarily on mucosal surfaces.

The SPC extends patent protection up to 5 years to offset delays in regulatory approval.

The fractional dose comes from the same full dose vaccine. It has been given to millions of people to prevent yellow fever in the past.

The primary reporter is the first person who provides individual safety information, regardless of whether the reporter is a medical professional.

If the applicant / marketing authorisation holder has submitted an RMP for the product, the RMP submitted later should adopt an updated format.

Antibody sequences can be identified via PCR, NGS, and bioinformatics analysis tools.

The exact number of protein sequence variants caused by post-translational modifications (PTMs), which alter proteins after synthesis, is unclear.